Treatment for Elevated Triglycerides

Introduction to Management

The American College of Cardiology recommends starting with aggressive lifestyle modifications for 3 months, then reassessing—if triglycerides remain elevated and the 10-year ASCVD risk is ≥7.5%, initiate moderate-intensity statin therapy, which will lower both LDL and triglycerides by 10-30% 1

Patients with triglyceride levels between 200-499 mg/dL are at increased cardiovascular risk, and the primary concern is long-term cardiovascular disease prevention, not acute pancreatitis, which becomes a risk only when triglycerides exceed 500 mg/dL 1
The American College of Cardiology suggests screening for secondary causes, such as hypothyroidism, diabetes, and medications that raise triglycerides, before initiating pharmacologic therapy 2

Targeting 5-10% body weight loss can produce a 20% decrease in triglycerides and is the single most effective intervention 2
Restricting added sugars to <6% of total daily calories can directly reduce hepatic triglyceride production 2
Limiting total dietary fat to 30-35% of calories, prioritizing polyunsaturated and monounsaturated fats over saturated fats, can help lower triglycerides 2
Eliminating trans fats completely is recommended 2
Increasing soluble fiber to >10 g/day from sources like oats, beans, and vegetables can help reduce triglycerides 2
Engaging in ≥150 minutes/week of moderate-intensity aerobic activity can reduce triglycerides by approximately 11% 2
Consuming ≥2 servings per week of fatty fish rich in omega-3 fatty acids can help lower triglycerides 2

The American College of Cardiology recommends initiating moderate-intensity statin therapy as first-line treatment for patients with a 10-year ASCVD risk ≥7.5% or diabetes, which can provide a 10-30% dose-dependent triglyceride reduction 1
Icosapent ethyl 2g twice daily can be considered for patients with persistently elevated triglycerides ≥135 mg/dL despite maximally tolerated statin therapy, established cardiovascular disease, or diabetes with ≥2 additional cardiovascular risk factors 1

Reassessing fasting lipid panel in 6-12 weeks after implementing lifestyle modifications is recommended 2
Reassessing lipids 4-8 weeks after initiating or adjusting statin therapy is recommended 2
Once goals are achieved, monitoring every 6-12 months is suggested 2